Journal profile · Infectious Diseases
LANCET INFECTIOUS DISEASES
ISSN 1473-3099 · eISSN 1474-4457 · Lancet Publishing Group · UNITED STATES · Monthly · Founded 2001
LANCET INFECTIOUS DISEASES: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 27.93; hybrid open access; APC about USD 7,280; median 48 days to acceptance (78 articles, last 24 months); community-reported acceptance: hard; 520 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
LANCET INFECTIOUS DISEASES is published by Lancet Publishing Group and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Viral Infections and Outbreaks Research, Tuberculosis Research and Epidemiology and Mosquito-borne diseases and control, together about 19.8% of its articles. Its main subfields are Infectious Diseases and Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical infectious diseases.
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Main research topics OpenAlex counts of recent articles; shares are approximate
- Viral Infections and Outbreaks ResearchMedicine7.1%
- Tuberculosis Research and EpidemiologyMedicine6.6%
- Mosquito-borne diseases and controlMedicine6.1%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.8%
- Pneumonia and Respiratory InfectionsMedicine5.1%
- Respiratory viral infections researchMedicine5.1%
- Malaria Research and ControlMedicine5%
- Vaccine Coverage and HesitancySocial Sciences4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Infectious Diseases | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Infectious Diseases | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Infectious Diseases | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 27.93LetPub ·
- Impact factor (publisher)
- 29.4Publisher website ·
- CiteScore 2026-06
- 39.2LetPub ·
- CiteScore (publisher)
- 39.2Publisher website ·
- SJR 2026-06
- 5.55LetPub ·
- SNIP 2026-06
- 6.2LetPub ·
- h-index
- 201LetPub ·
- h-index
- 376OpenAlex ·
- i10-index
- 4,172OpenAlex ·
- 2-year mean citedness
- 12.07OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 28.09%LetPub ·
Volume
- Articles per year
- 135LetPub ·
Articles by year OpenAlex count · 10,929 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 309 | 74 | 272 |
| 2025 | 520 | 186 | 4,331 |
| 2024 | 583 | 203 | 12,445 |
| 2023 | 521 | 303 | 12,916 |
| 2022 | 596 | 374 | 24,174 |
| 2021 | 578 | 406 | 30,884 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
48 daysMedian, submission to acceptance · P25–P75 22 days – 90 days
- Acceptance to online
- median 60 days (71 articles)
- Submission to online
- median 117 days
- Sample
- 78 articles with submission and acceptance dates (931 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- HardLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 19 daysPublisher website ·
- Submission to acceptance
- 28 daysPublisher website ·
- Acceptance to publication
- 69 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 7,280 / EUR 6,810 / GBP 5,830 / JPY 902,940 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lancet Publishing Group
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2001
- ISSN
- 1473-3099
- Electronic ISSN
- 1474-4457
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about LANCET INFECTIOUS DISEASES
What CAS zone is LANCET INFECTIOUS DISEASES in?
In the 2025 upgraded edition of the CAS Journal Ranking, LANCET INFECTIOUS DISEASES is in Zone 1 of Medicine, and in Zone 1 of the minor category Infectious Diseases; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of LANCET INFECTIOUS DISEASES?
The latest impact factor listed by LetPub is 27.93; CiteScore 39.2, h-index 376.
How long does peer review take at LANCET INFECTIOUS DISEASES?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 48 days (interquartile range 22–90 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index LANCET INFECTIOUS DISEASES?
According to LetPub and DOAJ records, LANCET INFECTIOUS DISEASES is indexed in SCIE and Scopus.
Is LANCET INFECTIOUS DISEASES open access, and what is the APC?
LANCET INFECTIOUS DISEASES is a hybrid journal. For open-access publication: APC about USD 7,280.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .